Cargando…
Development of latent Interferon alpha 2b as a safe therapeutic for treatment of Hepatitis C virus infection
Interferon therapy for the treatment of hepatitis C virus infection has very limited clinical application due to short serum half-life and side effects of therapy in systemic route of administration. In the present study, we have focused to improve the interferon therapy by overcoming the limitation...
Autores principales: | Gull, Iram, Aslam, Muhammad Shahbaz, Tipu, Imran, Mushtaq, Roohi, Ali, Tehseen Zamir, Athar, Muhammad Amin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6659634/ https://www.ncbi.nlm.nih.gov/pubmed/31350425 http://dx.doi.org/10.1038/s41598-019-47074-y |
Ejemplares similares
-
Heterologous expression, immunochemical and computational analysis of recombinant human interferon alpha 2b
por: Gull, Iram, et al.
Publicado: (2013) -
Use of Moringa oleifera Flower Pod Extract as Natural Preservative and Development of SCAR Marker for Its DNA Based Identification
por: Gull, Iram, et al.
Publicado: (2016) -
Phytochemical, toxicological and antimicrobial evaluation of lawsonia inermis extracts against clinical isolates of pathogenic bacteria
por: Gull, Iram, et al.
Publicado: (2013) -
Interferon α2–Thymosin α1 Fusion Protein (IFNα2–Tα1): A Genetically Engineered Fusion Protein with Enhanced Anticancer and Antiviral Effect
por: Aslam, Muhammad Shahbaz, et al.
Publicado: (2021) -
Cell-Free DNA Quantification and Methylation Status of DCC Gene as Predictive Diagnostic Biomarkers of Lung Cancer in Patients Reported at Gulab Devi Chest Hospital, Lahore
por: Aslam, Muhammad Shahbaz, et al.
Publicado: (2016)